|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 24.01 CNY | +2.52% |
|
+0.46% | -14.25% |
| 07-10 | China Includes Two Mayinglong Pharmaceutical Products in Essential Medicines List | MT |
| 05-25 | Mayinglong Pharmaceutical Gets Regulatory Approval for Eye Drops | MT |
| Market Cap | 10.35B 1.53B 1.34B 1.25B 1.15B 2.15B 146B 2.19B 14.82B 5.8B 72.44B 5.74B 5.62B 250B | P/E 2026 * |
15.4x | P/E 2027 * | 12.8x |
|---|---|---|---|---|---|
| Enterprise Value | 10.35B 1.53B 1.34B 1.25B 1.15B 2.15B 146B 2.19B 14.82B 5.8B 72.44B 5.74B 5.62B 250B | EV / Sales 2026 * |
2.4x | EV / Sales 2027 * | 2.18x |
| Free-Float |
64.65% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | +2.52% | ||
| 1 week | +0.46% | ||
| Current month | +11.05% | ||
| 1 month | +11.42% | ||
| 3 months | -7.51% | ||
| 6 months | -12.31% | ||
| Current year | -14.25% |
| 1 week | 23.04 |  | 24.05 |
| 1 month | 21.22 | | 24.69 |
| Current year | 21.22 | | 29.22 |
| 1 year | 21.22 | | 30.18 |
| 3 years | 20.2 | | 31.46 |
| 5 years | 17.99 | | 33.34 |
| 10 years | 12.52 | | 33.54 |
| Manager | Title | Age | Since |
|---|---|---|---|
You Zhang Xia
CEO | Chief Executive Officer | 48 | 28/05/2019 |
Tao Mao
DFI | Director of Finance/CFO | 49 | 28/12/2023 |
Ping An Liu
PRN | Corporate Officer/Principal | 40 | 19/08/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
Ping Chen
CHM | Chairman | 64 | 16/03/2010 |
You Zhang Xia
BRD | Director/Board Member | 48 | 28/05/2019 |
Ping An Liu
BRD | Director/Board Member | 40 | 14/06/2022 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.52% | +0.46% | -14.77% | -7.90% | 1.49B | |
| +1.93% | +3.85% | +51.05% | +166.24% | 1,068B | |
| +0.29% | +6.43% | +60.47% | +52.87% | 641B | |
| +2.45% | +2.77% | +39.61% | +74.48% | 454B | |
| +2.17% | +10.91% | +41.94% | +35.03% | 351B | |
| +1.46% | +5.93% | +40.44% | +43.69% | 299B | |
| +0.40% | +4.52% | +19.79% | +20.93% | 266B | |
| +2.73% | +2.26% | -25.81% | -36.98% | 220B | |
| +4.48% | +7.33% | +30.47% | +66.31% | 203B | |
| +2.91% | +3.10% | +18.84% | +74.76% | 162B | |
| Average | +2.31% | +2.71% | +26.20% | +48.94% | 366.48B | |
| Weighted average by Cap. | +2.04% | +2.85% | +40.07% | +80.11% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 4.32B 638M 560M 521M 480M 899M 60.95B 914M 6.18B 2.42B 30.22B 2.39B 2.34B 104B | 4.75B 702M 616M 574M 528M 990M 67.1B 1.01B 6.81B 2.67B 33.28B 2.64B 2.58B 115B |
| Net income | 674M 99.57M 87.39M 81.38M 74.85M 140M 9.51B 143M 965M 378M 4.72B 374M 366M 16.3B | 745M 110M 96.59M 89.95M 82.73M 155M 10.52B 158M 1.07B 418M 5.21B 413M 404M 18.02B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 28/07/26 | CN¥24.01 | +2.52% | 7,592,833 |
| 27/07/26 | CN¥23.42 | +1.12% | 4,953,662 |
| 24/07/26 | CN¥23.16 | -2.24% | 4,782,447 |
| 23/07/26 | CN¥23.69 | +0.94% | 4,964,162 |
| 22/07/26 | CN¥23.47 | -0.68% | 9,027,300 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 600993 Stock
Select your edition
All financial news and data tailored to specific country editions
